3-Chloro-1-cyclopropyl-7-methyl-5,6,7,8-tetrahydro-2,7-naphthyridine-4-carbonitrile

Catalog No. :
ACRNBR713
CAS No. :
1707568-81-7
Molecular Formula :
C13H14ClN3
Molecular Weight :
247.73

IUPAC Name:3-chloro-1-cyclopropyl-7-methyl-5,6,7,8-tetrahydro-2,7-naphthyridine-4-carbonitrile

3-Chloro-1-cyclopropyl-7-methyl-5,6,7,8-tetrahydro-2,7-naphthyridine-4-carbonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$561.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Chloro-1-cyclopropyl-7-methyl-5,6,7,8-tetrahydro-2,7-naphthyridine-4-carbonitrile
IUPAC Name3-chloro-1-cyclopropyl-7-methyl-5,6,7,8-tetrahydro-2,7-naphthyridine-4-carbonitrile
Molecular FormulaC13H14ClN3
Molecular Weight247.73
SMILESN#CC1=C(Cl)N=C(C2CC2)C3=C1CCN(C)C3
InChI KeyATRVUWHBZSSBGP-UHFFFAOYSA-N
Synonym3-Chloro-1-cyclopropyl-7-methyl-5,6,7,8-tetrahydro-[2,7]naphthyridine-4-carbonitrile;2,7-Naphthyridine-4-carbonitrile, 3-chloro-1-cyclopropyl-5,6,7,8-tetrahydro-7-methyl-
CAS No.1707568-81-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACRNBR713 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRNBR713 route product structure diagram
    ACRNBR7131707568-81-7
Inquiry

2. ACRNBR713 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRNBR713 route product structure diagram
    ACRNBR7131707568-81-7
Inquiry

Comments (0)